In this study, we address the role of tumour hypoxia, detected by HIF-1α IHC or hypoxic gene-expression signatures, in relation to outcome and benefit of RT in a large, randomised trial of postoperative RT in early breast cancer. This evidence concerns the gene HIF1A and neoplasm.